Page last updated: 2024-10-21

urea and Malignant Melanoma

urea has been researched along with Malignant Melanoma in 41 studies

pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.

Research Excerpts

ExcerptRelevanceReference
"Melanoma is a highly aggressive malignancy and early monitoring and diagnosis are challenging at present."5.48Ultrasensitive Tyrosinase-Activated Turn-On Near-Infrared Fluorescent Probe with a Rationally Designed Urea Bond for Selective Imaging and Photodamage to Melanoma Cells. ( Hu, L; Li, Z; Liang, XJ; Wang, YF; Zeng, C, 2018)
"Malignant melanomas are amongst the most aggressive cancers."5.48Modification, Biological Evaluation and SAR Studies of Novel 1H-Pyrazol Derivatives Containing N,N'-Disubstituted Urea Moiety as Potential Anti-melanoma Agents. ( Bu, CN; Dong, YL; Li, QS; Lin, MX; Ruan, BF; Shao, Q; Wang, TH; Xu, HJ; Zhang, Q; Zhou, BG, 2018)
"5-Iodo-2-thiouracil (ITU) is of interest due to its ability to bind specifically to the pigment melanin during melanogenesis and is of potential value in the diagnosis and treatment of malignant melanoma."3.67Direct electrophilic iodination of 2-thiouracil using Iodo-Gen. ( Coderre, JA; Halle, DA, 1989)
" The most common treatment-related treatment-emergent adverse events (TEAEs) of any grade in ≥15% of patients were increased lipase, alopecia, actinic keratosis, myalgia, arthralgia, decreased appetite, fatigue, hyperkeratosis, nausea, and palmar-plantar erythrodysesthesia syndrome."3.11Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma. ( Bauer, S; Chi, P; Janku, F; Jennings, J; Jones, RL; Meade, J; Psoinos, C; Ruiz-Soto, R; Shoumariyeh, K; Spreafico, A, 2022)
"Melanoma is a highly aggressive malignancy and early monitoring and diagnosis are challenging at present."1.48Ultrasensitive Tyrosinase-Activated Turn-On Near-Infrared Fluorescent Probe with a Rationally Designed Urea Bond for Selective Imaging and Photodamage to Melanoma Cells. ( Hu, L; Li, Z; Liang, XJ; Wang, YF; Zeng, C, 2018)
"Malignant melanomas are amongst the most aggressive cancers."1.48Modification, Biological Evaluation and SAR Studies of Novel 1H-Pyrazol Derivatives Containing N,N'-Disubstituted Urea Moiety as Potential Anti-melanoma Agents. ( Bu, CN; Dong, YL; Li, QS; Lin, MX; Ruan, BF; Shao, Q; Wang, TH; Xu, HJ; Zhang, Q; Zhou, BG, 2018)
"Malignant melanoma has an increasing incidence rate and the metastatic disease is notoriously resistant to standard chemotherapy."1.42Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma. ( Emilsen, E; Engesæter, B; Fjær, R; Flørenes, VA; Giller Fleten, K; Magnussen, GI; Nähse-Kumpf, V; Slipicevic, A, 2015)
"Malignant melanoma is the deadliest form of skin cancer, known for its drug resistance and high metastatic potential."1.37Melanoma prevention using topical PBISe. ( Amin, S; Chung, CY; Desai, D; Madhunapantula, SV; Robertson, GP, 2011)
"Malignant melanoma is the most deadly form of skin cancer due to its highly metastatic nature."1.35PBISe, a novel selenium-containing drug for the treatment of malignant melanoma. ( Amin, S; Desai, D; Huh, SJ; Madhunapantula, SV; Robertson, GP; Sharma, A, 2008)
"CTAB-urea treated RNA from highly pigmented melanoma cells can be successfully reverse transcribed and labeled to obtain probes which can be subsequently used in cDNA microarray experiments, giving consistent and reproducible results."1.32CTAB-urea method purifies RNA from melanin for cDNA microarray analysis. ( Carninci, P; De Cecco, L; Di Stasi, D; Gariboldi, M; Lagonigro, MS; Ranzani, T; Rodolfo, M, 2004)

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-199018 (43.90)18.7374
1990's2 (4.88)18.2507
2000's5 (12.20)29.6817
2010's11 (26.83)24.3611
2020's5 (12.20)2.80

Authors

AuthorsStudies
Janku, F1
Bauer, S1
Shoumariyeh, K1
Jones, RL1
Spreafico, A1
Jennings, J1
Psoinos, C1
Meade, J1
Ruiz-Soto, R1
Chi, P1
Flem-Karlsen, K1
McFadden, E1
Omar, N1
Haugen, MH1
Øy, GF1
Ryder, T1
Gullestad, HP1
Hermann, R1
Mælandsmo, GM1
Flørenes, VA2
Nguépy Keubo, FR1
Mboua, PC1
Djifack Tadongfack, T1
Fokouong Tchoffo, E1
Tasson Tatang, C1
Ide Zeuna, J1
Noupoue, EM1
Tsoplifack, CB1
Folefack, GO1
Kettani, M1
Bandelier, P1
Huo, J1
Li, H5
Yu, D1
Arulsamy, N1
AlAbbad, S1
Sardot, T1
Lekashvili, O1
Decato, D1
Lelj, F1
Alexander Ross, JB1
Rosenberg, E1
Nazir, H1
Muthuswamy, N1
Louis, C1
Jose, S1
Prakash, J1
Buan, MEM1
Flox, C1
Chavan, S1
Shi, X2
Kauranen, P1
Kallio, T1
Maia, G1
Tammeveski, K1
Lymperopoulos, N1
Carcadea, E1
Veziroglu, E1
Iranzo, A1
M Kannan, A1
Arunamata, A1
Tacy, TA1
Kache, S1
Mainwaring, RD1
Ma, M1
Maeda, K1
Punn, R1
Noguchi, S1
Hahn, S3
Iwasa, Y3
Ling, J2
Voccio, JP2
Kim, Y3
Song, J3
Bascuñán, J2
Chu, Y1
Tomita, M1
Cazorla, M1
Herrera, E1
Palomeque, E1
Saud, N1
Hoplock, LB1
Lobchuk, MM1
Lemoine, J1
Li, X10
Henson, MA1
Unsihuay, D1
Qiu, J1
Swaroop, S1
Nagornov, KO1
Kozhinov, AN1
Tsybin, YO1
Kuang, S1
Laskin, J1
Zin, NNINM1
Mohamad, MN1
Roslan, K1
Abdul Wafi, S1
Abdul Moin, NI1
Alias, A1
Zakaria, Y1
Abu-Bakar, N1
Naveed, A1
Jilani, K1
Siddique, AB1
Akbar, M1
Riaz, M1
Mushtaq, Z1
Sikandar, M1
Ilyas, S1
Bibi, I1
Asghar, A1
Rasool, G1
Irfan, M1
Li, XY1
Zhao, S1
Fan, XH1
Chen, KP1
Hua, W1
Liu, ZM1
Xue, XD1
Zhou, B1
Zhang, S2
Xing, YL1
Chen, MA1
Sun, Y1
Neradilek, MB1
Wu, XT1
Zhang, D2
Huang, W1
Cui, Y1
Yang, QQ1
Li, HW1
Zhao, XQ1
Hossein Rashidi, B1
Tarafdari, A1
Ghazimirsaeed, ST1
Shahrokh Tehraninezhad, E1
Keikha, F1
Eslami, B1
Ghazimirsaeed, SM1
Jafarabadi, M1
Silvani, Y1
Lovita, AND1
Maharani, A1
Wiyasa, IWA1
Sujuti, H1
Ratnawati, R1
Raras, TYM1
Lemin, AS1
Rahman, MM1
Pangarah, CA1
Kiyu, A1
Zeng, C3
Du, H1
Lin, D1
Jalan, D1
Rubagumya, F1
Hopman, WM1
Vanderpuye, V1
Lopes, G1
Seruga, B1
Booth, CM1
Berry, S1
Hammad, N1
Sajo, EA1
Okunade, KS1
Olorunfemi, G1
Rabiu, KA1
Anorlu, RI1
Xu, C2
Xiang, Y1
Xu, X1
Zhou, L2
Dong, X1
Tang, S1
Gao, XC1
Wei, CH1
Zhang, RG1
Cai, Q1
He, Y1
Tong, F1
Dong, JH1
Wu, G1
Dong, XR1
Tang, X1
Tao, F1
Xiang, W1
Zhao, Y3
Jin, L1
Tao, H1
Lei, Y1
Gan, H1
Huang, Y1
Chen, Y3
Chen, L3
Shan, A1
Zhao, H2
Wu, M2
Ma, Q1
Wang, J4
Zhang, E1
Zhang, J3
Li, Y5
Xue, F1
Deng, L1
Liu, L2
Yan, Z2
Wang, Y2
Meng, J1
Chen, G2
Anastassiadou, M1
Bernasconi, G1
Brancato, A1
Carrasco Cabrera, L1
Greco, L1
Jarrah, S1
Kazocina, A1
Leuschner, R1
Magrans, JO1
Miron, I1
Nave, S1
Pedersen, R1
Reich, H1
Rojas, A1
Sacchi, A1
Santos, M1
Theobald, A1
Vagenende, B1
Verani, A1
Du, L1
Liu, X1
Ren, Y1
Li, J7
Li, P1
Jiao, Q1
Meng, P1
Wang, F2
Wang, YS1
Wang, C3
Zhou, X2
Wang, W1
Wang, S2
Hou, J1
Zhang, A1
Lv, B1
Gao, C1
Pang, D1
Lu, K1
Ahmad, NH1
Wang, L1
Zhu, J2
Zhang, L2
Zhuang, T1
Tu, J1
Zhao, Z1
Qu, Y1
Yao, H1
Wang, X5
Lee, DF1
Shen, J3
Wen, L1
Huang, G2
Xie, X1
Zhao, Q1
Hu, W1
Zhang, Y4
Wu, X1
Lu, J2
Li, M1
Li, W2
Wu, W1
Du, F1
Ji, H1
Yang, X2
Xu, Z1
Wan, L1
Wen, Q1
Cho, CH1
Zou, C1
Xiao, Z1
Liao, J1
Su, X1
Bi, Z1
Su, Q1
Huang, H1
Wei, Y2
Gao, Y2
Na, KJ1
Choi, H1
Oh, HR1
Kim, YH1
Lee, SB1
Jung, YJ1
Koh, J1
Park, S1
Lee, HJ1
Jeon, YK1
Chung, DH1
Paeng, JC1
Park, IK1
Kang, CH1
Cheon, GJ1
Kang, KW1
Lee, DS1
Kim, YT1
Pajuelo-Lozano, N1
Alcalá, S1
Sainz, B1
Perona, R1
Sanchez-Perez, I1
Logotheti, S1
Marquardt, S1
Gupta, SK1
Richter, C1
Edelhäuser, BAH1
Engelmann, D1
Brenmoehl, J1
Söhnchen, C1
Murr, N1
Alpers, M1
Singh, KP1
Wolkenhauer, O1
Heckl, D1
Spitschak, A1
Pützer, BM1
Liao, Y1
Cheng, J1
Kong, X1
Li, S1
Zhang, M4
Zhang, H1
Yang, T2
Dong, Y1
Xu, Y1
Yuan, Z1
Cao, J1
Zheng, Y1
Luo, Z1
Mei, Z1
Yao, Y1
Liu, Z2
Liang, C1
Yang, H1
Song, Y1
Yu, K1
Zhu, C1
Huang, Z1
Qian, J1
Ge, J1
Hu, J2
Wang, H2
Liu, Y4
Mi, Y1
Kong, H1
Xi, D1
Yan, W1
Luo, X1
Ning, Q1
Chang, X2
Zhang, T2
Wang, Q2
Rathore, MG1
Reddy, K1
Chen, H1
Shin, SH1
Ma, WY1
Bode, AM1
Dong, Z1
Mu, W1
Liu, C3
Gao, F1
Qi, Y1
Lu, H1
Zhang, X4
Cai, X1
Ji, RY1
Hou, Y3
Tian, J2
Shi, Y1
Ying, S1
Tan, M1
Feng, G1
Kuang, Y1
Chen, D1
Wu, D3
Zhu, ZQ1
Tang, HX1
Shi, ZE1
Kang, J1
Liu, Q1
Qi, J2
Mu, J1
Cong, Z1
Chen, S2
Fu, D1
Li, Z4
Celestrin, CP1
Rocha, GZ1
Stein, AM1
Guadagnini, D1
Tadelle, RM1
Saad, MJA1
Oliveira, AG1
Bianconi, V1
Bronzo, P1
Banach, M1
Sahebkar, A1
Mannarino, MR1
Pirro, M1
Patsourakos, NG1
Kouvari, M1
Kotidis, A1
Kalantzi, KI1
Tsoumani, ME1
Anastasiadis, F1
Andronikos, P1
Aslanidou, T1
Efraimidis, P1
Georgiopoulos, A1
Gerakiou, K1
Grigoriadou-Skouta, E1
Grigoropoulos, P1
Hatzopoulos, D1
Kartalis, A1
Lyras, A1
Markatos, G1
Mikrogeorgiou, A1
Myroforou, I1
Orkopoulos, A1
Pavlidis, P1
Petras, C1
Riga, M1
Skouloudi, M1
Smyrnioudis, N1
Thomaidis, K1
Tsikouri, GE1
Tsikouris, EI1
Zisimos, K1
Vavoulis, P1
Vitali, MG1
Vitsas, G1
Vogiatzidis, C1
Chantanis, S1
Fousas, S1
Panagiotakos, DB1
Tselepis, AD1
Jungen, C1
Alken, FA1
Eickholt, C1
Scherschel, K1
Kuklik, P1
Klatt, N1
Schwarzl, J1
Moser, J1
Jularic, M1
Akbulak, RO1
Schaeffer, B1
Willems, S1
Meyer, C1
Nowak, JK1
Szczepanik, M1
Trypuć, M1
Pogorzelski, A1
Bobkowski, W1
Grytczuk, M1
Minarowska, A1
Wójciak, R1
Walkowiak, J1
Lu, Y1
Xi, J1
Li, C1
Chen, W2
Hu, X1
Zhang, F1
Wei, H1
Wang, Z1
Gurzu, S1
Jung, I1
Sugimura, H2
Stefan-van Staden, RI1
Yamada, H1
Natsume, H1
Iwashita, Y1
Szodorai, R1
Szederjesi, J1
Yari, D1
Ehsanbakhsh, Z1
Validad, MH1
Langroudi, FH1
Esfandiari, H1
Prager, A1
Hassanpour, K1
Kurup, SP1
Mets-Halgrimson, R1
Yoon, H1
Zeid, JL1
Mets, MB1
Rahmani, B1
Araujo-Castillo, RV1
Culquichicón, C1
Solis Condor, R1
Efendi, F1
Sebayang, SK1
Astutik, E1
Hadisuyatmana, S1
Has, EMM1
Kuswanto, H1
Foroutan, T1
Ahmadi, F1
Moayer, F1
Khalvati, S1
Zhang, Q3
Lyu, Y1
Huang, J1
Yu, N1
Wen, Z1
Hou, H1
Zhao, T1
Gupta, A1
Khosla, N1
Govindasamy, V1
Saini, A1
Annapurna, K1
Dhakate, SR1
Akkaya, Ö1
Chandgude, AL1
Dömling, A1
Harnett, J1
Oakes, K1
Carè, J1
Leach, M1
Brown, D1
Cramer, H1
Pinder, TA1
Steel, A1
Anheyer, D1
Cantu, J1
Valle, J1
Flores, K1
Gonzalez, D1
Valdes, C1
Lopez, J1
Padilla, V1
Alcoutlabi, M1
Parsons, J1
Núñez, K1
Hamed, M1
Fort, D1
Bruce, D1
Thevenot, P1
Cohen, A1
Weber, P1
Menezes, AMB1
Gonçalves, H1
Perez-Padilla, R1
Jarvis, D1
de Oliveira, PD1
Wehrmeister, FC1
Mir, S1
Wong, J1
Ryan, CM1
Bellingham, G1
Singh, M2
Waseem, R1
Eckert, DJ1
Chung, F1
Hegde, H1
Shimpi, N1
Panny, A1
Glurich, I1
Christie, P1
Acharya, A1
English, KL1
Downs, M1
Goetchius, E1
Buxton, R1
Ryder, JW1
Ploutz-Snyder, R1
Guilliams, M1
Scott, JM1
Ploutz-Snyder, LL1
Martens, C1
Goplen, FK1
Aasen, T1
Gjestad, R1
Nordfalk, KF1
Nordahl, SHG1
Inoue, T1
Soshi, S1
Kubota, M1
Marumo, K1
Mortensen, NP1
Caffaro, MM1
Patel, PR2
Uddin, MJ1
Aravamudhan, S1
Sumner, SJ1
Fennell, TR1
Gal, RL1
Cohen, NJ1
Kruger, D1
Beck, RW1
Bergenstal, RM1
Calhoun, P1
Cushman, T1
Haban, A1
Hood, K1
Johnson, ML1
McArthur, T1
Olson, BA1
Weinstock, RS1
Oser, SM1
Oser, TK1
Bugielski, B1
Strayer, H1
Aleppo, G1
Maruyama, H1
Hirayama, K1
Yamashita, M1
Ohgi, K1
Tsujimoto, R1
Takayasu, M1
Shimohata, H1
Kobayashi, M1
Buscagan, TM1
Rees, DC1
Jaborek, JR1
Zerby, HN1
Wick, MP1
Fluharty, FL1
Moeller, SJ1
Razavi, P1
Dickler, MN1
Shah, PD1
Toy, W1
Brown, DN1
Won, HH1
Li, BT1
Shen, R1
Vasan, N1
Modi, S1
Jhaveri, K1
Caravella, BA1
Patil, S1
Selenica, P1
Zamora, S1
Cowan, AM1
Comen, E1
Singh, A1
Covey, A1
Berger, MF1
Hudis, CA1
Norton, L1
Nagy, RJ1
Odegaard, JI1
Lanman, RB1
Solit, DB1
Robson, ME1
Lacouture, ME1
Brogi, E1
Reis-Filho, JS1
Moynahan, ME1
Scaltriti, M1
Chandarlapaty, S1
Papouskova, K1
Moravcova, M1
Masrati, G1
Ben-Tal, N1
Sychrova, H1
Zimmermannova, O1
Fang, J1
Fan, Y1
Luo, T2
Su, H1
Tsetseris, L1
Anthopoulos, TD1
Liu, SF1
Zhao, K1
Sacan, O1
Turkyilmaz, IB1
Bayrak, BB1
Mutlu, O1
Akev, N1
Yanardag, R1
Gruber, S1
Kamnoedboon, P1
Özcan, M1
Srinivasan, M1
Jo, YH1
Oh, HK1
Jeong, SY1
Lee, BG1
Zheng, J1
Guan, H1
Li, D2
Tan, H1
Maji, TK1
J R, A1
Mukherjee, S1
Alexander, R1
Mondal, A1
Das, S1
Sharma, RK1
Chakraborty, NK1
Dasgupta, K1
Sharma, AMR1
Hawaldar, R1
Pandey, M1
Naik, A1
Majumdar, K1
Pal, SK1
Adarsh, KV1
Ray, SK1
Karmakar, D1
Ma, Y2
Gao, W1
Ma, S1
Lin, W1
Zhou, T1
Wu, T1
Wu, Q1
Ye, C1
He, X1
Jiang, F1
Yuan, D1
Chen, Q1
Hong, M1
Chen, K1
Hussain, M1
Razi, SS1
Yildiz, EA1
Zhao, J1
Yaglioglu, HG1
Donato, MD1
Jiang, J1
Jamil, MI1
Zhan, X1
Chen, F1
Cheng, D1
Wu, CT1
Utsunomiya, T1
Ichii, T1
Fujinami, S1
Nakajima, K1
Sanchez, DM1
Raucci, U1
Ferreras, KN1
Martínez, TJ1
Mordi, NA1
Mordi, IR1
Singh, JS1
McCrimmon, RJ1
Struthers, AD1
Lang, CC1
Wang, XW1
Yuan, LJ1
Yang, Y1
Chen, WF1
Luo, R1
Yang, K1
Amarasiri, SS1
Attanayake, AP1
Arawwawala, LDAM1
Jayatilaka, KAPW1
Mudduwa, LKB1
Ogunsuyi, O2
Akanni, O1
Alabi, O1
Alimba, C1
Adaramoye, O1
Cambier, S1
Eswara, S1
Gutleb, AC1
Bakare, A1
Gu, Z1
Cong, J2
Pellegrini, M1
Palmieri, S1
Ricci, A1
Serio, A1
Paparella, A1
Lo Sterzo, C1
Jadeja, SD1
Vaishnav, J1
Mansuri, MS1
Shah, C1
Mayatra, JM1
Shah, A1
Begum, R1
Song, H2
Lian, Y1
Wan, T1
Schultz-Lebahn, A1
Skipper, MT1
Hvas, AM1
Larsen, OH1
Hijazi, Z1
Granger, CB1
Hohnloser, SH1
Westerbergh, J1
Lindbäck, J1
Alexander, JH1
Keltai, M1
Parkhomenko, A1
López-Sendón, JL1
Lopes, RD1
Siegbahn, A1
Wallentin, L1
El-Tarabany, MS1
Saleh, AA1
El-Araby, IE1
El-Magd, MA1
van Ginkel, MPH1
Schijven, MP1
van Grevenstein, WMU1
Schreuder, HWR1
Pereira, EDM1
da Silva, J1
Carvalho, PDS1
Grivicich, I1
Picada, JN1
Salgado Júnior, IB1
Vasques, GJ1
Pereira, MADS1
Reginatto, FH1
Ferraz, ABF1
Vasilenko, EA1
Gorshkova, EN1
Astrakhantseva, IV1
Drutskaya, MS1
Tillib, SV1
Nedospasov, SA1
Mokhonov, VV1
Nam, YW1
Cui, M1
Orfali, R1
Viegas, A1
Nguyen, M1
Mohammed, EHM1
Zoghebi, KA1
Rahighi, S1
Parang, K1
Patterson, KC1
Kahanovitch, U1
Gonçalves, CM1
Hablitz, JJ1
Staruschenko, A1
Mulkey, DK1
Olsen, ML1
Gu, L1
Cao, X1
Mukhtar, A1
Wu, K1
Zhang, YY1
Zhu, Y1
Lu, DZ1
Dong, W1
Bi, WJ1
Feng, XJ1
Wen, LM1
Sun, H1
Qi, MC1
Chang, CC1
Dinh, TK1
Lee, YA1
Wang, FN1
Sung, YC1
Yu, PL1
Chiu, SC1
Shih, YC1
Wu, CY1
Huang, YD1
Lu, TT1
Wan, D1
Sakizadeh, J1
Cline, JP1
Snyder, MA1
Kiely, CJ1
McIntosh, S1
Jiang, X1
Cao, JW1
Zhao, CK1
Yang, R1
Zhang, QY1
Chen, KJ2
Liu, H1
He, Z1
Chen, B1
Wu, J1
Du, X1
Moore, J1
Blank, BR1
Eksterowicz, J1
Sutimantanapi, D1
Yuen, N1
Metzger, T1
Chan, B1
Huang, T1
Chen, X1
Duong, F1
Kong, W1
Chang, JH1
Sun, J1
Zavorotinskaya, T1
Ye, Q1
Junttila, MR1
Ndubaku, C1
Friedman, LS1
Fantin, VR1
Sun, D1
Fei, P1
Xie, Q1
Jiang, Y1
Feng, H1
Chang, Y1
Kang, H1
Xing, M1
Chen, J1
Shao, Z1
Yuan, C1
Wu, Y1
Allan, R1
Canham, K1
Wallace, R1
Singh, D1
Ward, J1
Cooper, A1
Newcomb, C1
Nammour, S1
El Mobadder, M1
Maalouf, E1
Namour, M1
Namour, A1
Rey, G1
Matamba, P1
Matys, J1
Zeinoun, T1
Grzech-Leśniak, K1
Segabinazi Peserico, C1
Garozi, L1
Zagatto, AM1
Machado, FA1
Hirth, JM1
Dinehart, EE1
Lin, YL1
Kuo, YF1
Nouri, SS1
Ritchie, C1
Volow, A1
Li, B2
McSpadden, S1
Dearman, K1
Kotwal, A1
Sudore, RL1
Ward, L1
Thakur, A1
Kondadasula, SV1
Ji, K1
Schalk, DL1
Bliemeister, E1
Ung, J1
Aboukameel, A1
Casarez, E1
Sloane, BF1
Lum, LG1
Xiao, M1
Feng, X1
Gao, R1
Du, B1
Brooks, T1
Zwirner, J1
Hammer, N1
Ondruschka, B1
Jermy, M1
Luengo, A1
Marzo, I1
Reback, M1
Daubit, IM1
Fernández-Moreira, V1
Metzler-Nolte, N1
Gimeno, MC1
Tonchev, I1
Heberman, D1
Peretz, A1
Medvedovsky, AT1
Gotsman, I1
Rashi, Y1
Poles, L1
Goland, S1
Perlman, GY1
Danenberg, HD1
Beeri, R1
Shuvy, M1
Fu, Q1
Yang, D1
Sarapulova, A1
Pang, Q1
Meng, Y1
Wei, L1
Ehrenberg, H1
Kim, CC1
Jeong, SH1
Oh, KH1
Nam, KT1
Sun, JY1
Ning, J1
Duan, Z1
Kershaw, SV1
Rogach, AL1
Gao, Z1
Wang, T1
Li, Q1
Cao, T1
Guo, L1
Fu, Y1
Seeger, ZL1
Izgorodina, EI1
Hue, S1
Beldi-Ferchiou, A1
Bendib, I1
Surenaud, M1
Fourati, S1
Frapard, T1
Rivoal, S1
Razazi, K1
Carteaux, G1
Delfau-Larue, MH1
Mekontso-Dessap, A1
Audureau, E1
de Prost, N1
Gao, SS1
Duangthip, D1
Lo, ECM1
Chu, CH1
Roberts, W1
Rosenheck, RA1
Miyake, T1
Kimoto, E1
Luo, L1
Mathialagan, S1
Horlbogen, LM1
Ramanathan, R1
Wood, LS1
Johnson, JG1
Le, VH1
Vourvahis, M1
Rodrigues, AD1
Muto, C1
Furihata, K1
Sugiyama, Y1
Kusuhara, H1
Gong, Q1
Song, W1
Sun, B1
Cao, P1
Gu, S1
Sun, X1
Zhou, G1
Toma, C1
Khandhar, S1
Zalewski, AM1
D'Auria, SJ1
Tu, TM1
Jaber, WA1
Cho, J2
Suwandaratne, NS1
Razek, S1
Choi, YH1
Piper, LFJ1
Watson, DF1
Banerjee, S1
Xie, S1
Lindsay, AP1
Bates, FS1
Lodge, TP1
Hao, Y1
Chapovetsky, A1
Liu, JJ1
Welborn, M1
Luna, JM1
Do, T1
Haiges, R1
Miller Iii, TF1
Marinescu, SC1
Lopez, SA1
Compter, I1
Eekers, DBP1
Hoeben, A1
Rouschop, KMA1
Reymen, B1
Ackermans, L1
Beckervordersantforth, J1
Bauer, NJC1
Anten, MM1
Wesseling, P1
Postma, AA1
De Ruysscher, D1
Lambin, P1
Qiang, L1
Yang, S1
Cui, YH1
He, YY1
Kumar, SK1
Jacobus, SJ1
Cohen, AD1
Weiss, M1
Callander, N1
Singh, AK1
Parker, TL1
Menter, A1
Parsons, B1
Kumar, P1
Kapoor, P1
Rosenberg, A1
Zonder, JA1
Faber, E1
Lonial, S1
Anderson, KC1
Richardson, PG1
Orlowski, RZ1
Wagner, LI1
Rajkumar, SV1
Li, G1
Hou, G1
Cui, J1
Xie, H1
Sun, Z1
Fang, Z1
Dunstand-Guzmán, E1
Hallal-Calleros, C1
Hernández-Velázquez, VM1
Canales-Vargas, EJ1
Domínguez-Roldan, R1
Pedernera, M1
Peña-Chora, G1
Flores-Pérez, I1
Kim, MJ1
Han, C1
White, K1
Park, HJ1
Ding, D1
Boyd, K1
Rothenberger, C1
Bose, U1
Carmichael, P1
Linser, PJ1
Tanokura, M1
Salvi, R1
Someya, S1
Samuni, A1
Goldstein, S1
Divya, KP1
Dharuman, V1
Feng, J2
Qian, Y1
Cheng, Q1
Ma, H1
Ren, X1
Wei, Q1
Pan, W1
Guo, J1
Situ, B1
An, T1
Zheng, L1
Augusto, S1
Ratola, N1
Tarín-Carrasco, P1
Jiménez-Guerrero, P1
Turco, M1
Schuhmacher, M1
Costa, S1
Teixeira, JP1
Costa, C1
Syed, A1
Marraiki, N1
Al-Rashed, S1
Elgorban, AM1
Yassin, MT1
Chankhanittha, T1
Nanan, S1
Sorokina, KN1
Samoylova, YV1
Gromov, NV1
Ogorodnikova, OL1
Parmon, VN1
Ye, J1
Liao, W1
Zhang, P1
Nabi, M1
Cai, Y1
Li, F1
Alsbou, EM1
Omari, KW1
Adeosun, WA1
Asiri, AM1
Marwani, HM1
Barral, M1
Jemal-Turki, A1
Beuvon, F1
Soyer, P1
Camparo, P1
Cornud, F1
Atwater, BD1
Jones, WS1
Loring, Z1
Friedman, DJ1
Namburath, M1
Papirio, S1
Moscariello, C1
Di Costanzo, N1
Pirozzi, F1
Alappat, BJ1
Sreekrishnan, TR1
Volpin, F1
Woo, YC1
Kim, H2
Freguia, S1
Jeong, N1
Choi, JS1
Phuntsho, S1
Shon, HK1
Domínguez-Zambrano, E1
Pedraza-Chaverri, J1
López-Santos, AL1
Medina-Campos, ON1
Cruz-Rivera, C1
Bueno-Hernández, F1
Espinosa-Cuevas, A1
Bulavaitė, A1
Dalgediene, I1
Michailoviene, V1
Pleckaityte, M1
Sauerbier, P1
Köhler, R1
Renner, G1
Militz, H1
Rolfs, F1
Piersma, SR1
Dias, MP1
Jonkers, J1
Jimenez, CR1
Cruz, RCR1
Neto, FR1
Furtado, RA1
Souza, LM1
de Sousa, FD1
Ozelin, SD1
Bastos, JK1
Magalhães, GM1
Tavares, DC1
de Oliveira, PF1
Nieto Rodríguez, D1
Gómez Fernández, C1
Rueda Carnero, JM1
Wang, YF1
Hu, L1
Liang, XJ1
Ruan, BF1
Lin, MX1
Shao, Q1
Wang, TH1
Dong, YL1
Bu, CN1
Xu, HJ1
Zhou, BG1
Li, QS1
Yang, L1
Xie, J1
Cheng, X1
Fan, J1
Madhunapantula, SV3
Sharma, A2
Gowda, R1
Robertson, GP3
Koh, EJ1
El-Gamal, MI2
Oh, CH2
Lee, SH2
Sim, T2
Kim, G1
Choi, HS1
Hong, JH1
Lee, SG1
Yoo, KH2
Magnussen, GI1
Emilsen, E1
Giller Fleten, K1
Engesæter, B1
Nähse-Kumpf, V1
Fjær, R1
Slipicevic, A1
Melnikova, VO1
Bar-Eli, M1
Kim, JH1
Jang, YO1
Kim, BT1
Hwang, KJ1
Lee, JC1
Schmidt, J1
Garambois, V1
Rocheblave, L1
Martinez, J1
Pèlegrin, A1
Cavelier, F1
Vivès, E1
Fortin, S1
Bouchon, B1
Chambon, C1
Lacroix, J1
Moreau, E1
Chezal, JM1
Degoul, F1
C-Gaudreault, R1
Chung, CY1
Desai, D2
Amin, S2
Kim, HJ1
Cho, HJ1
Hah, JM1
Lagonigro, MS1
De Cecco, L1
Carninci, P1
Di Stasi, D1
Ranzani, T1
Rodolfo, M1
Gariboldi, M1
Knaggs, S1
Malkin, H1
Osborn, HM1
Williams, NA1
Yaqoob, P1
Huh, SJ1
Danopoulos, ED2
Danopoulou, IE2
Ghanem, G1
Legros, F1
Lejeune, F1
Frühling, J1
Thomasset, N1
Quash, GA1
Doré, JF1
Rieber, M1
Rieber, MS1
Mayer, P1
Schmid, H1
Schaber, B1
Fierlbeck, G1
Chilaris, GA1
Liaricos, SB1
Sugimura, K1
Ohno, T1
Kusuyama, T1
Azuma, I1
Coderre, JA1
Halle, DA1
Handel, SF1
Powell, MR1
Wilson, CB2
Enot, KJ2
Boldrey, EB1
Marsh, JC1
DeConti, RC1
Hubbard, SP1
Cohen, SM1
Greenspan, EM1
Weiner, MJ1
Kabakow, B1
Vrba, M1
Trávnícková, V1
Anton, M1
Rahi, AH1
Burnett, JB1
Ferry, AP1
Sugiura, K1
Tarnowski, GS1
Cappuccino, JG1
Schmid, FA1
Moon, JH1
Vogler, WR1
Bain, JA1
Huguley, CM1

Reviews

1 review available for urea and Malignant Melanoma

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021

Trials

5 trials available for urea and Malignant Melanoma

ArticleYear
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma.
    ESMO open, 2022, Volume: 7, Issue:4

    Topics: Adult; Gastrointestinal Stromal Tumors; Humans; Melanoma; Naphthyridines; Protein Kinase Inhibitors;

2022
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli

2021
1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
    Cancer chemotherapy reports, 1970, Volume: 54, Issue:4

    Topics: Adenocarcinoma; Adolescent; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Chordoma; Clinical

1970
Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:5

    Topics: Adenocarcinoma; Adenoma, Islet Cell; Adolescent; Adrenal Gland Neoplasms; Adult; Alkylating Agents;

1971
Triple combination chemotherapy of disseminated melanoma.
    Cancer, 1972, Volume: 29, Issue:6

    Topics: Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Combinati

1972

Other Studies

36 other studies available for urea and Malignant Melanoma

ArticleYear
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:3

    Topics: Animals; Apoptosis; Axl Receptor Tyrosine Kinase; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Pr

2020
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
    Molecular & cellular proteomics : MCP, 2021, Volume: 20

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line; Chloroform; DNA Damage; Feasibility Studies; Guanidin

2021
Watermelon Reduces the Toxicity of Cisplatin Treatment in C57BL/6 Mice with Induced Melanoma.
    Nutrition and cancer, 2022, Volume: 74, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Citrullus; Creatinine; Melanoma; Mice; Mice, Inbred C57BL

2022
Facial spiny follicular hyperkeratosis induced by vemurafenib.
    The Journal of dermatology, 2018, Volume: 45, Issue:2

    Topics: Aged; Antineoplastic Agents; Diagnosis, Differential; Face; Female; Humans; Keratosis; Melanoma; Sal

2018
Ultrasensitive Tyrosinase-Activated Turn-On Near-Infrared Fluorescent Probe with a Rationally Designed Urea Bond for Selective Imaging and Photodamage to Melanoma Cells.
    Analytical chemistry, 2018, 03-20, Volume: 90, Issue:6

    Topics: Animals; Cell Line, Tumor; Fluorescent Dyes; HeLa Cells; Humans; Melanoma; Methylene Blue; Mice; Mon

2018
Modification, Biological Evaluation and SAR Studies of Novel 1H-Pyrazol Derivatives Containing N,N'-Disubstituted Urea Moiety as Potential Anti-melanoma Agents.
    Chemistry & biodiversity, 2018, Volume: 15, Issue:6

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug

2018
UNBS5162 inhibits proliferation of human melanoma cells by inducing apoptosis via the PI3K/Akt pathway.
    Molecular medicine reports, 2018, Volume: 18, Issue:3

    Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Melanoma; Naphthalimides; Ph

2018
Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
    Pigment cell & melanoma research, 2013, Volume: 26, Issue:6

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; G1 Phase; Glycogen Synthase Kinase

2013
New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies.
    European journal of medicinal chemistry, 2013, Volume: 70

    Topics: Acetamides; Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Computer Simulation

2013
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.
    BMC cancer, 2015, Jun-10, Volume: 15

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Cyc

2015
Searching for the Achilles' heel of melanoma cells: new treatment modalities.
    Pigment cell & melanoma research, 2008, Volume: 21, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzenesulfonates; Clinical Trials as Topic; Enzyme Inhib

2008
Induction of caspase-dependent apoptosis in melanoma cells by the synthetic compound (E)-1-(3,4-dihydroxyphenethyl)-3-styrylurea.
    BMB reports, 2009, Dec-31, Volume: 42, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Proliferation; Cell Survival; DNA; Dose-Re

2009
Cyclization of peptides through a urea bond: application to the Arg-Gly-Asp tripeptide.
    Chembiochem : a European journal of chemical biology, 2010, May-17, Volume: 11, Issue:8

    Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Cyclization; Humans; Integrin alphaVb

2010
Characterization of the covalent binding of N-phenyl-N'-(2-chloroethyl)ureas to {beta}-tubulin: importance of Glu198 in microtubule stability.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 336, Issue:2

    Topics: Acetylation; Acylation; Animals; Antineoplastic Agents; Cells, Cultured; Humans; Melanoma; Mice; Mic

2011
Melanoma prevention using topical PBISe.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:6

    Topics: Administration, Topical; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cells, Cultured; Female

2011
New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line.
    Bioorganic & medicinal chemistry letters, 2012, May-01, Volume: 22, Issue:9

    Topics: Amides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Melanoma;

2012
CTAB-urea method purifies RNA from melanin for cDNA microarray analysis.
    Pigment cell research, 2004, Volume: 17, Issue:3

    Topics: Biotechnology; Cetrimonium; Cetrimonium Compounds; Detergents; DNA, Complementary; Melanins; Melanom

2004
New prodrugs derived from 6-aminodopamine and 4-aminophenol as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT).
    Organic & biomolecular chemistry, 2005, Nov-07, Volume: 3, Issue:21

    Topics: Aminophenols; Cell Line, Tumor; Cell Survival; Dopamine; Drug Delivery Systems; Drug Screening Assay

2005
PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Prolifer

2008
Eleven years experience of oral urea treatment in liver malignancies.
    Clinical oncology, 1981, Volume: 7, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Carcinoma, Hepatocellular; Drug Administration Sc

1981
Comparison and evaluation of different methods for alpha-MSH labelling.
    Journal of immunological methods, 1982, Oct-29, Volume: 54, Issue:2

    Topics: Animals; Cattle; Chloramines; Chromatography, Gel; Humans; Immune Sera; Immunologic Techniques; Iodi

1982
The differential contribution of arginase and transamidinase to ornithine biosynthesis in two achromic human melanoma cell lines.
    FEBS letters, 1982, Nov-01, Volume: 148, Issue:1

    Topics: Amidinotransferases; Arginase; Arginine; Cell Line; Glycine; Humans; Hydrogen-Ion Concentration; Mel

1982
Metastatic potential correlates with cell-surface protein alterations in B16 melanoma variants.
    Nature, 1981, Sep-03, Volume: 293, Issue:5827

    Topics: Animals; Cell Line; Cytoskeleton; Melanoma; Membrane Proteins; Mice; Molecular Weight; Neoplasm Meta

1981
Tumor-associated cysteine proteinase activities in human melanoma cells and fibroblasts of different origin.
    European journal of cell biology, 1997, Volume: 73, Issue:4

    Topics: Cell Line; Coumarins; Cysteine Endopeptidases; Diazomethane; Dipeptides; Fibroblasts; Humans; Hydrog

1997
Urea in the treatment of epibulbar malignancies.
    The British journal of ophthalmology, 1975, Volume: 59, Issue:5

    Topics: Aged; Carcinoma, Squamous Cell; Eye Neoplasms; Female; Humans; Male; Melanoma; Middle Aged; Powders;

1975
High sensitivity of human melanoma cell lines to the growth inhibitory activity of mycoplasmal arginine deiminase in vitro.
    Melanoma research, 1992, Volume: 2, Issue:3

    Topics: Antineoplastic Agents; Argininosuccinate Synthase; Bacterial Proteins; Base Sequence; Cell Division;

1992
Direct electrophilic iodination of 2-thiouracil using Iodo-Gen.
    International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes, 1989, Volume: 40, Issue:9

    Topics: Animals; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Melanins; Melanoma; Rad

1989
Scintiphotographic evaluation of response of brain neoplasms to systemic chemotherapy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1971, Volume: 12, Issue:6

    Topics: Adult; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Ependymoma; Follow-Up Studies; Frontal L

1971
[Genetics of malignant melanomas of the uvea].
    Ceskoslovenska oftalmologie, 1973, Volume: 29, Issue:3

    Topics: Adult; Aged; Chromosome Aberrations; Czechoslovakia; Eye Neoplasms; Female; Humans; Male; Melanoma;

1973
Autoimmune reactions in uveal melanoma.
    The British journal of ophthalmology, 1971, Volume: 55, Issue:12

    Topics: Aged; Autoantibodies; Choroid Neoplasms; Ciliary Body; Complement System Proteins; Cross Reactions;

1971
The tyrosinases of mouse melanoma. Isolation and molecular properties.
    The Journal of biological chemistry, 1971, May-25, Volume: 246, Issue:10

    Topics: Acrylates; Alcohols; Amino Acids; Animals; Catechol Oxidase; Chemical Phenomena; Chemistry; Chlorpro

1971
Primary malignant melanoma of the skin metastatic to the eye.
    American journal of ophthalmology, 1972, Volume: 74, Issue:1

    Topics: Adult; Blindness; Eye; Eye Neoplasms; Female; Humans; Inflammation; Male; Melanoma; Middle Aged; Neo

1972
Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and two related compounds on a spectrum of tumors.
    Cancer research, 1967, Volume: 27, Issue:3 Pt 2

    Topics: Adenocarcinoma; Animals; Carcinoma, Ehrlich Tumor; Carcinoma, Krebs 2; Fibrosarcoma; Glioma; Hydroxy

1967
Effect of 1, 3-diallylurea and related compounds on growth of transplanted animal tumors.
    Cancer research, 1967, Volume: 27, Issue:6

    Topics: Animals; Antineoplastic Agents; Carcinoma; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Female;

1967
Combination chemotherapy in malignant melanoma.
    Cancer, 1970, Volume: 26, Issue:2

    Topics: Adult; Bone Marrow Examination; Bone Neoplasms; Brain Neoplasms; Female; Hemoglobins; Humans; Inject

1970
In vivo effect of hydroxyurea on orotic acid synthesis.
    Cancer research, 1966, Volume: 26, Issue:9

    Topics: Adult; Aged; Antimetabolites; DNA; Humans; Leukemia; Melanoma; Middle Aged; Nucleosides; Orotic Acid

1966